Tag Archives: health

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

Jim Greenwood

In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John J. Castellani, president of PhRMA, write that context must accompany the data being provided under the Physician Payments Sunshine Act: “Discovery of new and improved medicines would be impossible without collaborations between physicians and biopharmaceutical companies. Consider ongoing research and clinical trials that not only make medicines possible, but also help our understanding of disease. Biopharmaceutical professionals help physicians stay Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Immuno Oncology – A 30-year Overnight Success Story

Photo Feb 11, 1 30 16 PM

“It was the Rodney Dangerfield space – couldn’t get no respect” One would never guess those words were used to describe immuno-oncology, a field that has recently bloomed into full-fledged frenzy – with private companies raising unprecedented Series As, impressive data being announced and Science designating the field “Breakthrough of the Year” all in 2013. Yet Dr. Jeffrey Weber, an early member in the “i-onc” research community likened the past several decades of immuno-oncology to Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

National Health Interview Survey: Adult Vaccination Rates Need Boost

Copyright sanofi pasteur

The Centers for Disease Control and Prevention (CDC) recently released immunization coverage estimates from the 2012 National Health Interview Survey (NHIS) for six vaccines routinely recommended for adults including pneumococcal, tetanus and Tdap, Hepatitis A, Hepatitis B, herpes zoster (shingles), and Human papillomavirus (HPV). These data indicate little overall improvement in vaccination coverage among adults from 2011 to 2012. Compared with 2011, modest increases occurred in three vaccines: Tdap, herpes zoster and HPV. However, vaccination Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Doping Undermines the Mission of Biotechnology

Sochi Flame

The Olympic Games in Sochi captures the world’s attention as athletes compete to bring home gold. Our industry plays a key role in helping to maintain the integrity and honor of sports and competition by remaining vigilant in our anti-doping efforts. Doping undermines the integrity of our industry’s core mission of serving patients through drug discovery and development. The same medicines that can be used to help children with devastating genetic deficiencies and growth disorders, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

FDA Week: For Biologics, A Name Isn’t Just A Name (Jim Greenwood op-ed)

Jim Greenwood

What is in a name? Names help make medicinal products more easily distinguishable by doctors, pharmacists and patients. When you are talking about biologics, complex medicines that are manufactured using living organisms, and biosimilars, medicines that are similar to, but not the same as, innovator biologics, naming is a significant consideration. As a pathway for biosimilars approval is implemented, a clear priority should be to craft a naming convention that both contributes to patient safety Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,